Subgroup analysis in meta-analysis: what does it show, and how should you interpret it?

A subgroup analysis meta-analysis asks whether an intervention’s effect differs across levels of a characteristic, such as a study or participant feature. The key evidence is a direct test of the difference between subgroup effects—often called an interaction test—not whether one subgroup’s result is statistically significant while another’s is not. [1]

The interpretation depends on what the review can actually compare. Analyses based on study characteristics can identify patterns across trials, but they are observational comparisons and may be confounded by other trial differences. If the question is whether a characteristic changes treatment response for individual participants, participant-level data and within-trial comparisons may be needed. [1][2]

What question does a subgroup analysis answer?

A subgroup analysis tests whether the estimated intervention effect varies across categories of a characteristic. The characteristic might describe participants or studies, but those are different questions: a pattern across studies does not, by itself, establish that individual participants with a particular feature respond differently. [1]

Start by defining the proposed effect modifier and the level at which it is measured. For example, a trial-level question concerns differences between studies classified by a study characteristic; a participant-level question concerns whether treatment effects differ between people with different characteristics within trials. Keeping that distinction explicit helps prevent a study-level association from being interpreted as an individual response pattern. [1][2]

Subgroup analysis can help investigate heterogeneity, but a pattern is not an explanation simply because it appears across categories. Consider whether the hypothesis is plausible, whether the groups are defined clearly, and whether the evidence supports a direct comparison of effects. [1][3]

Why is “significant in one group, not the other” not enough?

Because separate significance tests do not test whether the subgroup effects differ. One subgroup can have a statistically significant estimate and another a non-significant estimate even when the difference between their effects is not itself statistically significant. The relevant evidence is a direct test of the between-subgroup difference or interaction. [1]

Interpret that test alongside the effect estimates and their uncertainty. A non-significant interaction does not prove that effects are identical across subgroups. A significant interaction does not, on its own, show that the characteristic causes a difference in response or that the difference is clinically useful. [1][4]

In practice, avoid replacing the interaction result with a comparison of subgroup-specific P values. Report the subgroup estimates, their uncertainty, and the interaction evidence, then discuss whether the pattern is plausible and important. This keeps statistical evidence distinct from the strength of the broader claim. [1][4]

How should you plan and test a subgroup analysis?

Plan the hypothesis before examining the results, define the groups and cut-points, and choose a direct method suited to the data. More credible hypotheses are clinically or methodologically plausible, prespecified with clear categories, tested directly, and supported by consistent or replicated evidence. Identify analyses developed after seeing the data as post hoc. [1][3]

A review protocol should explain why each subgroup is being examined, how its groups are defined, and what statistical approach will be used. PROSPERO guidance calls for a prospective, review-specific synthesis plan; the protocol should be ready and submitted before data extraction begins, and changes should be documented. Consult the supplied guidance for current eligibility and form requirements. [6]

Limit the analysis plan to hypotheses that have a clear rationale. When many subgroup hypotheses are examined, the resulting pattern needs careful interpretation: isolated findings can be difficult to distinguish from chance or other limitations. The available guidance supports prespecification and credible appraisal but does not provide a specific multiplicity-control method. [1][3]

Systematic-review automation can help teams keep subgroup definitions, coding decisions, protocol plans, and deviations traceable for human review. It cannot remove confounding, create information the evidence does not contain, or replace methodological judgment about whether a result is credible. [1][6]

When are meta-regression and IPD approaches appropriate?

Meta-regression can examine whether continuous or categorical study characteristics are associated with differences in study effects. Its results depend on how many studies are available and how those studies are distributed across the characteristic. Cochrane gives at least 10 studies per modelled characteristic as a rule of thumb, not a guarantee of adequate power or validity. [1]

Use meta-regression cautiously when study features may be entangled with other differences between trials. Because these are study-level observational comparisons, an association between a study characteristic and effect estimates does not establish that individual patients with that characteristic experience a different treatment effect. [1]

When the question is participant-level effect modification, individual participant data (IPD) can support treatment-by-subgroup comparisons within trials. A two-stage approach estimates trial-specific interactions and pools them. A one-stage model needs to account for clustering by trial and distinguish within-trial information from between-trial information. [2]

The choice between these approaches follows the question and available data. Do not treat a trial-level meta-regression as a substitute for within-trial evidence when the claim concerns individual participants. [1][2]

How can subgroup analyses help explain heterogeneity—and where can they mislead?

Subgroup analyses can help investigate whether differences in estimated effects align with a prespecified study or participant characteristic. That makes them one possible way to explore variation across results, but not proof of what caused it. Study characteristics may be confounded with other differences between trials. [1]

A subgroup pattern is more persuasive when its rationale was established in advance, the categories are clearly defined, the interaction is tested directly, and evidence is consistent or replicated. A post-hoc pattern or one based on sparse evidence deserves particular caution; the amount of evidence in the smallest subgroup is also relevant to assessing credibility. [1][3][5]

Keep statistical and practical interpretations separate. An interaction may be statistically supported without establishing causation or clinical usefulness, while a non-significant interaction may leave meaningful differences uncertain. Consider the estimates, uncertainty, plausibility, prespecification, study-level confounding, and clinical importance together. [1][4]

Key takeaways

• A subgroup analysis asks whether intervention effects differ across levels of a characteristic, and the relevant test directly compares those effects. [1]
• Different subgroup-specific significance results do not establish a subgroup difference; interpret the interaction test and estimates together. [1]
• Study-level subgroup analyses and meta-regressions are observational comparisons and may be confounded by differences between trials. [1]
• Cochrane’s guideline of at least 10 studies per modelled meta-regression characteristic is a rule of thumb, not a guarantee of adequacy. [1]
• For participant-level effect modification, IPD can support within-trial interaction analyses, with trial structure handled appropriately. [2]
• Prespecify subgroup rationale, group definitions, and the analysis approach, and document protocol changes. [6]

FAQ

How do I conduct a subgroup analysis in meta-analysis?

Define a plausible hypothesis, specify the groups and cut-points, and plan a direct interaction test before examining results. Report subgroup estimates and uncertainty, and identify any analysis that was developed after looking at the data as post hoc. [1][3]

What are the limitations of subgroup analysis in meta-analysis?

Study-level comparisons can be confounded by other differences between trials, and sparse or uneven evidence can limit what the analysis supports. A non-significant interaction does not prove identical effects, and a significant one does not establish causation or usefulness. [1][4]

How does subgroup analysis help in understanding heterogeneity?

It can examine whether effect estimates vary with a specified study or participant characteristic. The pattern is an investigation of heterogeneity, not proof that the characteristic explains it. [1]

What statistical methods are used for subgroup analysis in meta-analysis?

Methods include direct tests of between-subgroup differences, meta-regression for study characteristics, and IPD models for participant-level treatment-by-subgroup comparisons. The appropriate method depends on the question and data structure. [1][2]

What should I include in a PROSPERO subgroup plan?

Describe the subgroup rationale, group definitions, and planned statistical approach in a prospective, review-specific synthesis plan. The protocol should be ready and submitted before data extraction begins, and changes should be documented; use PROSPERO’s guidance for current registration requirements. [6]